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Simulated microgravity (SMG) bioreactors and DNA microarray technology are
powerful tools to identify “space genes” that play key roles in cellular response
to microgravity. We applied these biotechnology tools to investigate SMG and
post-SMG recovery effects on human epidermal keratinocytes by exposing cells to
SMG for 3, 4, 9, and 10 d using the high aspect ratio vessel bioreactor followed by
recovery culturing for 15, 50, and 60 d in normal gravity. As a result, we identif ied
162 differentially expressed genes, 32 of which were “center genes” that were most
consistently affected in the time course experiments. Eleven of the center genes
were from the integrated stress response pathways and were coordinately down-
regulated. Another seven of the center genes, which are all metallothionein MT-I
and MT-II isoforms, were coordinately up-regulated. In addition, HLA-G, a key
gene in cellular immune response suppression, was found to be signif icantly up-
regulated during the recovery phase. Overall, more than 80% of the differentially
expressed genes from the shorter exposures (≤4 d) recovered in 15 d; for longer
(≥9 d) exposures, more than 50 d were needed to recover to the impact level of
shorter exposures. The data indicated that shorter SMG exposure duration would
lead to quicker and more complete recovery from the microgravity effect.
Key words: HEK001, HARV, DNA microarray, Northern blotting, expression profiling, micro-
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Introduction
Exposure to microgravity has been recognized as a
major environmental factor of spaceflight. Some of
the adverse effects resulting from spaceflight are a
decline in cellular immune response (1–3 ), cardiovas-
cular deconditioning (4 ), bone deterioration (5 ), and
muscular atrophy (6 ). Elucidation of the molecular
mechanisms underlying microgravity-induced health
problems is critical for formulating effective counter-
measures for spaceflight side-effects. Due to the cost
effectiveness and the ability to separate micrograv-
ity effect from other complex factors of spaceflight,
ground-based simulated microgravity (SMG) research
has become popular and is widely practiced in space
life sciences research.
Ground-based SMG conditions for mammalian
cell and microorganism cultures are created through
the use of high aspect ratio vessel (HARV) bioreactors
(7 , 8 ), which simulate microgravity by maintaining
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the cells in continuous free fall in liquid medium and
are most commonly used in the United States (9–
12 ). The HARV bioreactor does not allow the cells
to receive a gravitational load in any fixed direc-
tion. Its constant rotation does not eliminate grav-
ity, but it does allow the g-vector to be time-averaged
to near zero (13 ). Ground-based SMG experiments
using bioreactors such as HARV have become increas-
ingly recognized as an effective approach in simulating
certain aspects of microgravity, as it readily permits
the more detailed experimentation towards the under-
standing of microgravity effects on genes and cellular
activities during microgravity exposure.
Understanding gene and cellular activity changes
in microgravity is essential for tackling the problems
caused by microgravity exposure and for developing
potential countermeasures. Studies at the cellular
and molecular levels have been reported from both
spaceflight and ground-based microgravity simulators
such as HARV (10, 14–17 ). Microgravity has been
found to influence major cellular events such as cell
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proliferation, cell cycle, cell differentiation, and pro-
grammed cell death (18–20 ). Many cell types, rang-
ing from bacteria to mammalian cells, are sensitive to
the microgravity environment, suggesting that micro-
gravity affects fundamental cellular activities. The
study of microgravity effects on cellular activities can
benefit enormously from genome-wide gene expres-
sion technologies.
Gene expression profiling based on DNA mi-
croarrays is a genome-wide gene expression analysis
method for assessing cellular and molecular activity
changes in response to a change in the growth envi-
ronment. Environmental change as drastic as sud-
den gravity change is likely to alter the functions
and transcriptional activities of groups of genes. A
genome-wide display and comparison of gene expres-
sion profiles in cells that are exposed to micrograv-
ity and different recovery stages could provide great
insight into the array of genes that are directly or
indirectly involved in gravity response. This is be-
cause any change in the physiological activity of a
cell is most likely the result of changes in the ex-
pression of certain genes. Thus, the genome-wide ex-
pression analysis technology can be a powerful tool
to identify the “space genes” that play key roles in
cellular response to a microgravity environment. In
recent years, microarray technology has become in-
creasingly popular in space biosciences research and
most of the microgravity-induced cellular and molec-
ular effects have been reported on cells of the immune
system (21 , 22 ), muscle (23–26 ), and bone (12, 27–
30 ). However, it is not clear if the affected cellular
functions would recover once the cells are returned to
1 g conventional growth conditions.
To further understand the cellular and molecular
mechanisms by which spaceflight alters cellular ac-
tivities, the effects of microgravity on various human
cell lines should be studied to identify the genes whose
functions are most consistently affected by micrograv-
ity. Epidermal keratinocytes, the major cell type in
the outermost layer of the skin, play an essential role
in the first-line defense against invading microorgan-
isms and in innate immunity (31 , 32 ). To date, the
molecular effect of microgravity on keratinocytes is
not known. Thus, the aim of this study was to dis-
play time course gene expression profiles and identify
key gravity sensitive genes for human kerotinocytes in
response to microgravity. We studied the micrograv-
ity effect on a basal-like type of immortalized human
epidermal keratinocytes, HEK001, using the HARV
bioreactor SMG system. We applied DNA microar-
ray analysis for genome-wide expression profiling of
the cells exposed to HARV bioreactor SMG condi-
tions for 3, 4, 9, and 10 d, followed by recovery of
15, 50, and 60 d at 1 g. Our results indicated that
cellular gene activity achieved >80% recovery from
the shorter exposure time (≤4 d) in a recovery pe-
riod of 15 d, while a longer recovery period (≥50 d)
was needed for genes to recover to the shorter ex-
posed impact levels after an exposure time as long as
9 and 10 d. In addition, we have identified 32 puta-
tive “major space genes” that were most consistently
affected by SMG through the interlinked time course
analysis. Interestingly, a cluster of eleven genes that
are inducible through the integrated stress response
pathways were all down-regulated in the presence of
SMG. In contrast, a cluster of seven metallothionein
genes were up-regulated through all the time points.
Moreover, HLA-G, a key gene that mediates cellular
immune suppression effect, was up-regulated during
the recovery phase of SMG exposure. Our findings
contribute significantly to the knowledge of epidermal
response to SMG, which may suggest a mechanism in
the whole body response to microgravity, particularly
in microgravity-associated immune response suppres-
sion, integrated stress response, and tumor progres-
sion.
Results
Morphology of HEK001 cells cultured
in HARV bioreactors and in conven-
tional 2D cell culture flasks
Monolayer keratinocytes, HEK001 cells, formed small
aggregates and spherical cellular morphology (Figure
1C and E) typical for cells cultured in the 3D environ-
ment of HARV bioreactors. When the HEK001 cells
were removed from the HARV bioreactors after the
shorter (3 and 4 d) SMG exposures and then cultured
in conventional 2D cell culture flasks for 15 d, the
keratinocytes spread out to form monolayer growth
indistinguishable from the untreated controls (com-
pare Figure 1A and B with D and F). Cells from the
longer (9 and 10 d) SMG exposures were not recov-
ered as complete as the shorter ones, and elongated
cells were found in the recovery culture after 16 d
(Figure 1G and H). Figure 1G shows cells after 7-day
recovery from a 9-day SMG treatment; note that cell
aggregates were visible at the early recovery stage.
Although these cells regained their morphological
Geno. Prot. Bioinfo. Vol. 6 No. 1 2008 9
Microarray Analysis of Human Keratinocytes in SMG
BA
G
D
E
H
F
C
Fig. 1 Morphology of HEK001 cells cultured in HARV bioreactors for SMG treatment and in conventional 2D cell
culture flasks for normal gravity recovery. A and B. HEK001 cells cultured in normal gravity tissue culture flasks
showing different photo fields and magnifications of the control cells. C. Cell aggregates from 3-day SMG culture. D.
Cells recovering from 3-day SMG treatment in Panel C by 15-day growth in normal (1 g) gravity (culture flasks). E.
Cell aggregates from 4-day SMG treatment. F. Cells recovering from 4-day SMG treatment through 15-day culture
in normal gravity. G. Cells after 7-day recovery in normal gravity from 9-day SMG treatment. H. Cells after 16-day
recovery in normal gravity from 10-day SMG treatment.
appearance after extended culturing under normal
gravity, the extent to which cellular gene activity was
affected by the SMG treatments and whether the al-
tered gene functions would ever recover were of cru-
cial interest. Therefore, we next investigated through
DNA microarray analysis for genome-wide gene ex-
pression evaluation and through Northern blotting for
gene-specific validation.
General gene expression profiles and
distributions of the time course mi-
croarray data
To visualize the general gene expression profiles of
the microarray data, we first plotted the extracted
microarray data in MA plots (Figure 2). In the MA
plots, each point represents one feature from a corre-
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Fig. 2 MA scatter plots showing the average trend of the log ratio as a function of intensity of features in Arrays 1–5
using Lowess normalization. Each point represents one feature from the corresponding microarray. F633 represents the
intensity of the red (R) laser wavelength (633 nm) that excites the cyanine 5 dye. F545 represents the intensity of the
green (G) laser wavelength (545 nm) that excites the cyanine 3 dye. The MA plot shows the log intensity ratio M=
log2(R/G) versus the average intensity A= 1/2(log2R+log2G). A. MA plot for 3-day SMG (Array 1). B. MA plot for
4-day SMG (Array 2). C. MA plot for 4-day SMG followed by 15-day recovery at 1 g (Array 3). D and E. MA plots
for 9-day and 10-day SMG followed by 50-day and 60-day recovery at 1 g, respectively (Arrays 4 and 5).
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sponding microarray. The plots of five different
microarray experiments before and after normaliza-
tion show the general gene expression profiles of the
cells exposed to different doses of SMG and dur-
ing different recovery periods (Arrays 1–5; Figure
2A–E). After normalization and statistical analysis
(student t-test) of the microarray data, a total of
314 differentially regulated genes from the five time
course microarrays were identified as statistically sig-
nificant (p ≤0.05). We further filtered the 314 genes
to a cut-off point of 1.5-fold up- or down-regulation.
Thus, a total of 162 genes were identified from the
five SMG experiments to be significantly (≥1.5-fold
change, p ≤0.05) differentially expressed, constitut-
ing the initial pool of the putative gravity sensitive
genes in the SMG-treated keratinocytes (see Table 1
in Appendix). The numbers of differentially regu-
lated genes allocated for each of the five (Arrays 1–5)
microarrays were 101, 94, 18, 105, and 86, respec-
tively. These putative gravity sensitive genes of the
keratinocytes were subjected to further bioinformatics
analysis.
Functional grouping and time course
expression profiles of the 162 gravity
sensitive genes
The significantly differentially expressed genes in
each of the five experiments were further categorized
into 18 functional groups using histograms as shown
in Figure 3. For each experiment, the number of genes
induced (red) and suppressed (blue) was graphed for
each of the 18 functional categories, generating an in-
dividual histogram profile for the corresponding mi-
croarray. Figure 3A shows the functional distribution
of 101 SMG-affected genes exposed to 3-day micro-
gravity (Array 1) with 34 induced and 67 suppressed.
Those exposed to 4-day SMG (Array 2) exhibited a
similar expression pattern, with 32 genes up-regulated
and 62 down-regulated (Figure 3B). In contrast, the
cells that were cultured for 4-day SMG and then re-
cultured and grown at 1 g for 15 d recovered from
the microgravity effect more efficiently, with only 18
genes exhibiting significant differential regulation (10
up and 8 down) (Figure 3C). The cells that were
grown in SMG for 9 and 10 d followed by recovery
culturing at 1 g for 50 and 60 d, respectively, exhib-
ited a similar expression pattern to each other and
to the first two time points (compare Figure 3D and
E with A and B). The effect of the longer exposures
followed by the near two-month recovery time seemed
to be equivalent to the shorter exposures without re-
covery. Most notably across the four similar profiles
(Figure 3A, B, D, E), cellular functions affected by
SMG mainly were metabolism, cell communication,
cell development, and cell death. The data suggest a
critical role of the recovery growth in mitigating the
alteration of cellular gene functions from prolonged
SMG exposure. The recovery effect was even more
apparent in Array 3 (Figure 3C), which showed that
only 18 genes were differentially expressed compared
with the non-treated control, while >80% of the genes
had returned to homeostasis after 15-day recovery in
normal gravity.
Cluster analysis of genes differentially
expressed under microgravity and re-
covery
The 162 differentially regulated genes were clustered
hierarchically into five clusters (Figure 4; Table 1)
using average-linkage clustering (33 ). Cluster I was
coordinately down-regulated, consisting of 14 genes,
11 of which were from the integrated stress response
pathway. The genes in Cluster I from the cells cul-
tured for 3 d (Array 1) and 4 d (Array 2) in SMG
were on average down-regulated ∼3.8 fold. When al-
lowed to recover at 1 g for 15 d (Array 3), >80%
of these genes recovered to non-exposed level. The
genes that were exposed to SMG for 9 and 10 d and
were allowed to recover at 1 g for 50 d (Array 4) and
60 d (Array 5), respectively, showed a level of down-
regulation similar to those exposed to SMG for 3 and
4 d. Cluster II has 83 genes. The expression pattern
was very similar between 3-day and 4-day SMG, with
the average down-regulation of ∼1.7 fold, and similar
between 9-day and 10-day SMG followed by 50-day
and 60-day recovery at 1 g, respectively, with the av-
erage down-regulation of ∼1.5 fold. This cluster did
not show significant differential expression after ex-
posure to 4-day SMG followed by 15-day recovery at 1
g. There are 17 genes represented in Cluster III. The
average expression level for 3-day and 4-day SMG ex-
posure was ∼2 fold. Again, this cluster did not show
significant differential expression after exposure to 4-
day SMG followed by 15-day recovery. Cluster IV is
comprised of eight metallothione genes that were all
up-regulated across the five time points. The level of
up-regulation was ∼2 fold across the first three time
points. After 9-day SMG followed by 50-day recovery,
the Cluster IV gene expression increased to ∼4-fold
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Fig. 3 Functional grouping and time course expression
profiles of gravity sensitive genes. The gene expression
profiles of the 162 putative gravity sensitive genes that
were statistically significant (p≤0.05) and showed at least
1.5-fold up- or down-regulation from the five experiments
were categorized into 18 functional groups and displayed
as histograms. The red histograms represent the up-
regulated genes and the blue histograms represent down-
regulated genes. A. Category of 101 differentially reg-
ulated genes exposed to 3-day SMG. B. Category of 93
differentially regulated genes exposed to 4-day SMG. Note
that the patterns of gene regulation exhibited in Panels A
and B are very similar. C. Category of 18 differentially
genes exposed to 4-day SMG followed by 15-day recovery
at 1 g. D. Category of 105 differentially regulated genes
exposed to 9-day SMG followed by 50-day recovery. E.
Category of 95 differentially regulated genes exposed to
10-day SMG followed by 60-day recovery.
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Fig. 4 Cluster analysis of 162 differentially regulated genes from five microarray experiments showing the trend in time
course. A. The average-linkage hierarchal clustering of the expression data (log2) of all the 162 significant genes. The
rows represent individual genes categorized into five hierarchical clusters according to differential expression levels. The
columns represent the five microarray experiments showing the gene expression pattern for each time point according
to the five clusters. B. The time course trend of expression of all of the genes represented in each cluster.
up-regulation. After 10-day SMG followed by 60-day
recovery, however, the Cluster IV gene expression re-
turned to the level similar to the levels of the shorter
exposure time points (∼2-fold up-regulation). It may
be that an additional 10 more days’ recovery time was
needed to allow the longest exposed cells to recover to
the impact level of shorter exposed cells. In Cluster
V (40 genes), there was an average up-regulation of
∼1.5 fold after 3-day and 4-day SMG and a drop to
little (no differential regulation or complete recovery)
after 15-day recovery. However, for 9-day and 10-day
SMG followed with recovery at 1 g for 50 and 60 d,
it showed a similar expression pattern (∼1.6-fold up-
regulation) to those cultured under SMG for 3 and 4
d. Thus, the close to two-month recovery time again
reduced the SMG effect to the level of shorter expo-
sures for the 40 genes in this cluster.
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Overlapping patterns of differentially
expressed genes among the five SMG
experiments and the identification of
“center genes”
When comparing Arrays 1 and 2 for the 3-day and
4-day SMG (Figure 5A) using the Venn diagram,
we found that a total of 76 differentially regulated
genes (27 up and 49 down) were common to both
microarrays, showing a consistency of ∼75% between
the two different time points. A total of merely 18
differentially expressed genes in Array 3 indicated
that >80% of the genes had recovered from the 4-day
microgravity effect after 15 d in normal gravity cul-
ture. Out of these 18 significant genes, there were 17
and 16 genes shared with the 3-day and 4-day micro-
gravity treatment alone, respectively; this constituted
about 90% of all the significant genes identified from
Array 3. The data suggest a causal link for the rem-
nant SMG affected genes, which resulted from having
not yet completely recovered from the SMG treat-
ment. Figure 5B allowed us to further compare the ex-
pression patterns between the shorter exposures alone
and the longer exposures followed with up to a two-
month recovery period (Arrays 4 and 5). We found a
significant overlap of the differentially regulated genes
among the four different time points. Similar to the
two shorter exposures (3-day and 4-day SMG) shown
Fig. 5 Venn diagrams of overlapping gene expression
patterns of the 162 significant genes across the five time
points. The red numbers represent up-regulated genes
and the blue numbers represent down-regulated genes. A.
Comparison of gene expression data of 3-day and 4-day
SMG exposure with 4-day SMG exposure followed by 15-
day recovery at 1 g. B. Comparison of gene expression
data of 3-day and 4-day SMG exposure with 9-day SMG
followed by 50-day recovery and 10-day SMG followed by
60-day recovery. The center of the Venn diagrams shows
that there are 32 differentially regulated genes between
all four array experiments. C. Heat map of the expression
pattern for the 32 differentially regulated genes identified
from the center of the Venn diagrams in Panel B.
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in Figure 5A, the two longer exposures (plus longer re-
covery) shared ∼69% common differentially expressed
genes. An important function of the Venn diagram is
that it allowed us to readily identify the genes affected
by all the SMG treatments through the center of the
diagrams: all four time point microarrays shared 32
genes (13 up and 19 down) that are differentially reg-
ulated by at least 1.5 fold (Figure 5B and C). These
“center genes” were the best candidates for the “ma-
jor space genes” because they were most consistently
affected by SMG.
Validation of microarray results
through Northern blotting analysis of
ten cellular genes
We also performed Northern hybridization to verify
the results from the microarray analysis of the SMG
time course experiments. The uniqueness of Northern
blotting analysis is that it measures the abundance as
well as the size of the RNA of interest (34 ). Figure
6 shows the size identity and expression levels for ten
genes, nine of which were significant genes identified
through microarray experiments, and GAPDH was
used as an internal control. The Northern hybridiza-
tion reactions were performed sequentially with the
ten cDNA probes as shown in the figure. All the hy-
bridizations shown in the figure resulted in one pre-
dominant band of the expected sizes (marked with ar-
rows) for the particular mRNAs. However, some mi-
nor bands were visible in a few panels. For the TRIB3
probe, the level of the larger band (∼2,500 to 2,800
bp) was down-regulated in SMG; the expression level
for another isoform (alternatively spliced) of TRIB3
mRNA (Figure 6C) did not seem to be affected by
SMG. There was a higher band found in lanes 1, 4,
and 5 of Figure 6G (MT1A probe), which most likely
resulted from the incomplete stripping of the TRA1
probe hybridized immediately prior to the hybridiza-
tion of MT1A.
The bands of the expected sizes for the probed
mRNA (marked with arrows) were subjected to
quantitative analysis. To quantitatively analyze the
mRNA levels from the Northern blots, we first nor-
malized all the mRNA bands in Figure 6A–J against
the GAPDH level in each corresponding lane. The
normalized levels of the mRNA in each panel were
then plotted in histograms as shown in Figure 7.
The overall Northern blotting results demonstrated
a remarkable resemblance to those obtained from mi-
croarray analysis, with an overall high level of cor-
relation between the results from the two methods
(R=0.86; Figure 7). The mRNA levels for genes
PDIA4, TRIB3, AREG, TRA1, PCK2, and ARMET
were shown to be decreased significantly by both mi-
croarray analysis and Northern blotting, with cor-
relation coefficient values of 0.97, 0.84, 0.98, 0.69,
0.91, and 0.93, respectively. The MT1X, MT2A, and
MT1A mRNA levels were found to be significantly
increased by both microarray and Northern blotting
analysis, with correlation coefficient values of 0.58,
0.85, and 0.97, respectively. The overall high level of
correlation (R=0.86) between the analytical results
from microarray and Northern blotting further vali-
dated our genome-wide analysis using the microarray
technology.
Discussion
Microgravity effects have been closely associated with
bone loss, muscle atrophy, and decreased immune
function of astronauts. Consequently, extensive stud-
ies on cells of the bone, muscle, and blood origin
have been documented in literature (18–20 ). Since
astronauts experience whole body exposure to micro-
gravity, all the organ systems in the body are poten-
tially affected by the gravity change and may function
differently to counterbalance the microgravity stress.
The different organ systems may react differently to
gravity change. It is also possible that a common set
of genes in different cell lineages are preferentially al-
tered in microgravity conditions. To fully understand
the microgravity effect on human health, it is impor-
tant to study the microgravity response of cells of var-
ious organ origins. The identification of the common
set of gravity sensitive genes may lead to the iden-
tification of “major space genes” that together play a
major check-and-balance role ultimately determining
the outcome of a cell, or an organism such as an indi-
vidual person, in the response to microgravity condi-
tions.
The gene expression profiles for the five time
points were achieved mainly from the 18 functional
groups of genes in histograms and hierarchical cluster
analysis of all the 162 significantly differentially reg-
ulated genes. The nearly identical expression profiles
between the 3-day and 4-day SMG treatment indi-
cated a high level of consistency in the number and
type of gravity sensitive genes between the closely
spaced time points (Figure 3A and B). Similar ex-
pression profiles were also found between longer time
16 Geno. Prot. Bioinfo. Vol. 6 No. 1 2008
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Fig. 6 Validation of microarray results using Northern blotting analysis of genes differently expressed under modeled
microgravity conditions. An amount of 10 µg total RNA from each sample was loaded onto a 1% formaldehyde agarose
gel. Lanes 1–7 were loaded with samples as the following: Lane 1, conventional stationary control; Lane 2, three-
day modeled microgravity; Lane 3, four-day modeled microgravity; Lane 4, three-day microgravity recovery; Lane 5,
four-day microgravity recovery; Lane 6, nine-day microgravity recovery; Lane 7, ten-day microgravity recovery. The
Northern blot was sequentially hybridized with ten different probes as indicated in Panels A–J: A. PDIA4; B. MT1X;
C. TRIB3; D. AREG; E. MT2A: F. TRA1; G. MT1A: H. PCK2; I. ARMET; J. GAPDH. The expected mRNA band
for each probe was indicated with an arrow to the right side of each panel.
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Fig. 7 Quantitative comparison of gene expression data obtained from Northern blotting analysis and microarray
analysis. The mRNA bands in Figure 6A–J were first normalized against the GAPDH level in each corresponding
lane. The normalized levels of the mRNA in each panel were then plotted in histograms as shown in Figure 7A–I. In
the histograms, the Northern blotting data (blue) were plotted side by side with the microarray data (red) to directly
compare the expression levels of the same nine significant genes. The values of the correlation coefficient (R values)
for each comparison were indicated in each panel.
points, that is, cells recovering from 9-day and 10-
day SMG treatment in normal gravity for 50 and 60
d, respectively (Figure 3D and E). The validity of the
microarray data was further confirmed with Northern
blotting analysis of ten genes (Figures 6 and 7). For
SMG exposure time as short as 4 d, a 15-day recovery
period resulted in >80% of the SMG affected gene
expression returning to homestasis (compare Figure
3C with B). A two-month recovery period mitigated
the affected gene expression profile to that equivalent
to the 4-day SMG exposure level. Thus, our expres-
sion profiling results suggest that the time duration of
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microgravity exposure as well as post-SMG recovery
are critical determinants of the extent to which cellu-
lar gene expression is affected by SMG. The shorter
the SMG exposure and the longer the recovery time,
the better the recovery from the SMG stress. Based
on our results, it is advisable that shorter mission
duration time and longer recovery interval would be
beneficial to astronauts’ health.
We further identified 32 “key” or “center” gravity
sensitive genes from the 162 significantly differentially
regulated genes detected from the time course experi-
ments. This was achieved by the use of Venn diagrams
of the shorter SMG exposures (3-day and 4-day SMG)
and the longer exposures (9-day and 10-day SMG fol-
lowed by 50-day and 60-day recovery) locating the
genes that were in the very center of the four inter-
linked time points (Figure 5B and C). These genes
were considered to be most consistently impacted
by the microgravity treatment because they were
affected by all the interlinked time points of the SMG
exposures. These key gravity sensitive genes may be
candidates for the “major space genes” whose activi-
ties were most significantly affected by the SMG en-
vironmental factor and most likely play a determinant
role coordinately on the outcome of the SMG expo-
sure effects. Many of these genes were found to be co-
ordinately regulated in specific clusters belonging to
particular pathways and are known to be coordinately
regulated in non-space environment. One of the most
notable groups of coordinately regulated genes was
the eleven “center genes” (AREG, HSPA5, HER-
PUD1, PDIA4, PCK2, SDF2L1, TRIB3, SREBF1,
TRA1, ASNS, and ARMET) that all came from Clus-
ter I and were all down-regulated in SMG (Figure 5C;
Table 1). These genes are known to be coordinately
regulated in integrated stress response pathways such
as the endoplasmic reticulum (ER) stress response
pathway and the amino acid starvation response path-
way (35 , 36 ). They are typically induced coordinately
in the presence of ER stress or in response to amino
acid starvation (35 , 36 ). It is not clear why these
genes were all down-regulated under reduced gravity
conditions. It maybe that microgravity is favorable
for protein folding and transport, making the machin-
ery for the ER protein unfold stress response pathway
unnecessary. To our knowledge, this is the first report
to connect this set of integrated stress response genes
to microgravity response. Nonetheless, in a study
comparing the gene expression from cells grown in mi-
crogravity on the space shuttle with those grown in
SMG, TRA1 was found to be down-regulated for 5.5
fold and 1.2 fold, respectively (37 ). In agreement with
the reported space shuttle and SMG results, TRA1 in
our experiment was also down-regulated across all the
time points (from ∼3.2 fold to ∼1.75 fold) in SMG.
TRA1 has also been found to be up-regulated in a va-
riety of tumor cells in response to glucose depletion,
hypoxia, and decreased pH. Therefore, TRA1 seems
to be implicated in cell immunity against cancer cells
(38 ).
Another group of coordinately regulated genes
that were also found in the center of the four in-
terlinked time points includes seven metallothionein
genes (MT1A, MT1B, MT1G, MT1H, MT1X, MT2A,
and a MT2A clone ENST00000245185) in Cluster IV.
These genes were all major isoforms of metalloth-
ioneins and were up-regulated in all the SMG time
points, even more significant during recovery periods
(Figure 4 and Figure 5C; Table 1). Consistent with
our result, MT1A and MT2A expressions have been
found to be up-regulated in space-flown (16 d) rat
skeletal muscles (20 ). MT-I and MT-II isoforms have
very similar structures and functions and are coordi-
nately regulated in most cells (39 , 40 ). They have
cellular functions primarily in metal ion homeosta-
sis, scavenging of ROS, redox status, immune defense
responses, cell proliferation, and cell death (40 , 41 ).
MT-I and MT-II are induced by most inflammatory
or pathological stimulus such as proinflammatory cy-
tokines and oxidative stress (42 ). In addition, our
microarray data showed several genes involved in
immune response such as HLA-G and IL-1β to be
affected by SMG (Table 1, Cluster V). Although IL-
1β induction has been reported in a macrophage cell
line in space (43 ), it is not known whether HLA-G
gene expression would be altered by microgravity. In
normal gravity environment, HLA-G has been shown
to have direct inhibitory effect on T, APC, and NK
cell functions in the immune system and induces sup-
pressor T-cells. HLA-G also plays a role in tumor-
driven immune escape mechanism of cancer cells dur-
ing the later phase in host and tumor cell interactions
(44 ). Our finding that HLA-G mRNA levels were up-
regulated in microgravity-exposed keratinocytes may
suggest an underlining mechanism for microgravity-
associated immune response suppression.
Conclusion
In summary, our results indicated that cellular gene
activity achieved >80% recovery from the shorter ex-
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posure time (≤4 d) in a recovery period of 15 d,
while a longer recovery period (≥50 d) was needed
for genes to recover to the shorter exposed impact
levels after an exposure time as long as 9 and 10
d. Interestingly, a cluster of eleven genes in the inte-
grated stress response pathway that are inducible by
ER stress and amino acid starvation were all down-
regulated in the presence of SMG. In contrast, a num-
ber of genes involved in proliferation, development,
and cancer were up-regulated. A cluster of seven met-
allothionein genes were all up-regulated through all
the time points. In addition, HLA-G, a key gene that
mediates cellular immune suppression effect, was up-
regulated during recovery phases of SMG exposure.
Our findings contribute significantly to the knowledge
of epidermal response to SMG, which may suggest a
mechanism in the whole body response to micrograv-
ity, particularly in microgravity-associated immune
response suppression, integrated stress response, and
tumor progression. Overall, the data suggests, for
health’s sake, shorter mission duration in space may
lead to quicker and more complete recovery from the
microgravity effects.
Materials and Methods
Cell culture
HEK001, an immortalized human skin keratinocyte
cell line of basal-like type (45 ), was purchased from
American Type Culture Collection (Manassas, VA,
USA) and cultured at 37◦C with 95% humidity and
5% CO2 in Ketatinocyte-Serum Free medium with 5
ng/mL human recombinant EGF, 50 ug/mL bovine
pituitary extract, and 2 mM L-glutamine.
Simulated microgravity and cell expo-
sure
Ground-based modeled microgravity was achieved us-
ing the 50 mL HARV units of the rotating wall vessel
(RWV) culture apparatus (a NASA JSC invention)
from Synthecon, Inc (Houston, TX, USA). Cell viabil-
ity and cell concentration were determined by Vi-Cell
1.01 cell counter of Beckman Coulter (Fullerton, CA,
USA). For the 3-day and 4-day modeled microgravity
exposures, a density of 2.0×105 cell/mL with viability
of 93.2% of the HEK001 cells were cultured in RWV
bioreactors at 17.2 rpm to achieve the constant free-
fall experience for cell aggregates. At the end of the
3-day and 4-day microgravity exposure, the contents
of the bioreactor vessels were poured out into a 50
mL sterile centrifuge tube to collect cell pellets, and 5
mL of the cell suspension from the bioreactor vessels
was transferred to T75 flasks for morphological ob-
servation and for further stationary culture. Hence,
the recovery stage for the exposed cells as well as post
3-day and post 4-day microgravity recovery cell sam-
ples were achieved. After the removal of the cells from
the vessels, fresh medium was used to refill the ves-
sels for extended microgravity exposure to 9 and 10
d, respectively. The resulted cells were all transferred
to stationary culture for recovery of 50 and 60 d, with
medium change twice per week. Non-exposed station-
ary controls and the recovery stage of microgravity-
exposed HEK001 cells were cultured in tissue culture
flasks with vented caps (TPP Techno Plastic Prod-
ucts, Trasadingen, Switzerland) in the same incubator
at 37◦C with 5% CO2.
Total RNA isolation and DNA microar-
ray hybridization
HEK001 cells cultured in modeled microgravity
HARV bioreactors and control flasks were removed
at their respective time points, washed with PBS for
three times and lysed in guanidinium isothiocyanate
buffer. The cell lysates were stored at −80◦C prior to
ultracentrifugation for total RNA isolation (46 , 47 ).
Total cellular RNA was labeled using the Agilent Low
RNA Input fluorescent Linear Amplification Kit (Ag-
ilent Technologies, Santa Clara, CA, USA) following
the manufacturer’s protocols (48 ). The fluorescently
labeled cRNA probes were further purified and hy-
bridized to Agilent 22K Human Microarray V2 ac-
cording to the specified procedures within the kit.
Microarray scanning, feature extrac-
tion, and functional grouping
The microarrays were scanned using a ScanArray
microarray scanner (Perkin-Elmer, Waltham, MA,
USA). The images generated from the scanning were
imported into GenePix 6.0 (Molecular Devices, Sun-
nyvale, CA, USA) for alignment and initial quanti-
tation. Lowess normalization and some statistical
analyses were performed in Acuity 4.0 (Molecular De-
vices). The normalized genes were then subjected to
a student t-test to determine statistical significance.
An alteration in gene expression level was considered
significant if it passed a statistically significant level
of p ≤0.05 and met the minimum cut-off of 1.5-fold
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differential regulation. The significant genes thus
identified were further processed using EASE (49 ) to
identify 18 functional categories and relevant path-
ways. The functional categories were then used to
organize the gene table (Table 1) and to generate the
comparative histograms (Figure 3).
Hierarchical clustering and Venn dia-
grams
We also used the average-linkage hierarchical cluster-
ing to better organize and visualize the expression
patterns in the data (33 , 50 ). The hierarchical clus-
tering was performed using Genesis 1.0 (51 ). To more
easily identify the genes affected by all the SMG treat-
ments, we generated Venn diagrams using AFM 4.0
(52 ).
Northern blotting, normalization, and
quantitative analysis
Some of the significantly regulated microgravity sen-
sitive genes identified from the DNA microarray anal-
ysis were further verified using Northern blotting.
Briefly, 10 µg total RNA was loaded per lane on a
1% formaldehyde agarose gel for electrophoresis sepa-
ration of RNA species. The gel-separated RNAs were
capillarilly transferred onto a nylon membrane, which
was subjected to a hybridization procedure using
chemilluminascently (Pierce Biotechnology, Rockford,
IL, USA) labeled cDNA probe fragments. The blot
was sequentially hybridized with ten different probe
fragments. The cDNA probe fragments were gener-
ated from RT-PCR reactions using total cellular RNA
as the templates. RT-PCR reactions were carried out
to generate the cDNA probes required for the North-
ern blotting analysis, using the Reverse Transcription
System of Promega (Madison, WI, USA) and the Bio-
Line Red DNA Polymerase PCR kit (Taunton, MA,
USA). For Northern blot quantitation, the autoradio-
graphs of the Northern blots were scanned and saved
as TIF images for further analysis. The images were
then opened in Unscan-It Gel (Silk Scientific, Orem,
UT, USA) for quantitation. To quantitatively analyze
the mRNA levels from the Northern blots, we first
normalized the mRNA bands in Figure 6A–J against
the GAPDH level in each corresponding lane. The
normalized levels of the mRNA in each panel were
then plotted in histograms as shown in Figure 7.
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Appendix
Table 1 Identif ication and clustering of 162 putative gravity sensitive genes*
Accession No. Gene symbol 1# 2# 3# 4# 5# Gene description Biological process
CLUSTER I
NM 001657 AREG -11.43 -10.72 1.13 -1.73 -3.25 amphiregulin (schwannoma-derived
growth factor)
Cell communication
NM 006010 ARMET -2.78 -2.77 -1.43 -1.83 -1.85 arginine-rich, mutated in early stage
tumors
Unknown
NM 001673 ASNS -2.87 -3.32 1.31 -3.99 -1.59 asparagine synthetase (ASNS), tran-
script variant 2
Amino acid
metabolism
NM 004343 CALR -3.08 -2.92 -1.77 -1.49 -1.75 calreticulin Cell cycle
NM 014685 HERPUD1 -4.61 -4.44 -1.94 -3.04 -3.52 homocysteine-inducible, endoplasmic
reticulum stress-inducible, ubiquitin-
like domain member 1, transcript vari-
ant 1
Protein metabolism
NM 004134 HSPA5 -4.98 -4.25 -2.03 -2.87 -3.49 heat shock 70 kDa protein 5 (glucose-
regulated protein, 78 kDa)
Cell cycle
NM 013417 IARS -3.95 -3.42 -3.87 -2.37 isoleucine-tRNA synthetase (IARS),
transcript variant long
Protein metabolism
NM 004563 PCK2 -4.18 -4.17 1.37 -3.14 -1.88 phosphoenolpyruvate carboxykinase 2
(mitochondrial), nuclear gene encod-
ing mitochondrial protein, transcript
variant 1
Glucose metabolism
NM 004911 PDIA4 -4.28 -3.12 -2.63 -2.42 -2.50 protein disulfide isomerase family A,
member 4
Unknown
NM 006623 PHGDH -2.53 -3.63 1.39 -5.59 -2.00 phosphoglycerate dehydrogenase Development
NM 022044 SDF2L1 -3.68 -3.46 -3.05 -2.63 stromal cell-derived factor 2-like 1 Unknown
NM 001005291 SREBF1 -3.64 -4.55 -1.30 -2.04 -1.69 sterol regulatory element binding tran-
scription factor 1, transcript variant 1
Cellular lipid
metabolism
NM 003299 TRA1 -3.26 -3.21 -1.75 -2.20 -2.59 tumor rejection antigen (gp96) 1 Cell cycle
NM 021158 TRIB3 -3.68 -4.76 1.48 -5.98 -3.09 tribbles homolog 3 (Drosophila) Unknown
CLUSTER II
NM 001605 AARS -1.73 -1.83 -1.01 -1.43 -1.22 alanyl-tRNA synthetase Protein metabolism
NM 001001937 ATP5A1 -1.64 -1.12 1.04 -1.20 -1.25 ATP synthase, H+ transporting, mito-
chondrial F1 complex, alpha subunit,
isoform 1
Development
NM 001697 ATP5O -2.06 -1.93 1.09 -1.39 -1.60 ATP synthase, H+ transporting, mito-
chondrial F1 complex, O subunit
Development
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Table 1 Continued
Accession No. Gene symbol 1# 2# 3# 4# 5# Gene description Biological process
BC000228 BC000228 -3.02 -1.83 -2.23 -1.41 -2.03 Similar to transducin-like enhancer of
split 1, homolog of Drosophila E (sp1)
Unknown
NM 032621 BEX2 -2.86 -2.69 -1.22 -1.57 brain expressed X-linked 2 Unknown
NM 001005266 C15orf21 -2.40 -3.07 -1.58 -1.43 chromosome 15 open reading frame 21,
transcript variant 1
Unknown
NM 001009924 C20orf30 -1.71 -1.11 -1.41 -1.35 chromosome 20 open reading frame 30,
transcript variant 2
Unknown
NM 000071 CBS -1.98 -1.93 -1.91 -1.38 cystathionine-beta-synthase Amino acid
metabolism
NM 014550 CARD10 -1.47 -1.38 -1.52 -1.29 caspase recruitment domain family,
member 10
Cell cycle
NM 004360 CDH1 -1.52 -1.77 -1.96 -1.63 cadherin 1, type 1, E-cadherin (epithe-
lial)
Cell adhesion
NM 025233 COASY -1.51 -1.32 Coenzyme A synthase Unknown
NM 001316 CSE1L -1.26 -1.62 -1.57 -1.52 CSE1 chromosome segregation 1-like
(yeast), transcript variant 1 Cell cycle
D00022 D00022 -1.57 -1.32 -1.01 -1.33 -1.13 mRNA for F1 beta subunit, complete
cds
Unknown
NM 032552 DAB2IP -1.24 -1.85 -1.33 -1.19 DAB2 interacting protein, transcript
variant 1
Unknown
NM 004394 DAP -1.66 -1.29 1.05 -1.27 -1.13 death-associated protein Cell cycle
NM 033657 DAP3 -1.23 -1.28 -1.01 -1.61 -1.24 death-associated protein 3 Cell cycle
NM 001919 DCI -3.00 -3.51 -1.55 dodecenoyl-Coenzyme A delta iso-
merase (3,2-trans-enoyl-Coenzyme A
isomerase), nuclear gene encoding mi-
tochondrial protein
Cellular lipid
metabolism
NM 001360 DHCR7 -1.51 -1.52 -1.51 -1.95 7-dehydrocholesterol reductase Cellular lipid
metabolism
NM 006824 EBNA1BP2 -1.56 -1.22 -1.31 -1.09 EBNA1 binding protein 2 Cell organization
and biogenesis
NM 006579 EBP -1.54 -1.58 -1.25 -1.43 emopamil binding protein (sterol iso-
merase)
Development
NM 001398 ECH1 -1.73 -1.63 -1.27 -1.60 enoyl Coenzyme A hydratase 1, perox-
isomal
Cellular lipid
metabolism
NM 001404 EEF1G -1.65 -1.51 -1.29 -1.30 -1.44 eukaryotic translation elongation fac-
tor 1 gamma
Protein metabolism
NM 013234 EIF3S12 -1.66 -1.28 -1.27 -1.12 eukaryotic translation initiation factor
3, subunit 12
Unknown
NM 003756 EIF3S8 -1.45 -1.51 -1.55 -1.62 eukaryotic translation initiation factor
3, subunit 3 gamma, 40 kDa
Protein metabolism
BC047866 ENST 00000265423 -1.78 -1.26 -1.12 -1.06 chromosome 6 open reading frame 62,
mRNA (cDNA clone MGC:57512 IM-
AGE:6499979)
Unknown
NM 004446 EPRS -1.96 -1.91 -1.24 glutamyl-prolyl-tRNA synthetase Protein metabolism
NM 144503 F11R -1.10 -1.14 -1.56 -1.36 F11 receptor Immune response
NM 004470 FKBP2 -2.51 -2.09 -1.09 -1.73 -1.55 FK506 binding protein 2, 13 kDa, tran-
script variant 1
Protein metabolism
NM 003910 G10 -1.59 -1.78 1.16 -1.48 -1.28 maternal G10 transcript Transcrition
NM 002047 GARS -1.70 -1.61 1.02 -1.56 -1.36 glycyl-tRNA synthetase Protein metabolism
NM 014394 GHITM -1.79 -1.88 -2.24 -1.70 growth hormone inducible transmem-
brane protein
Unknown
NM 006098 GNB2L1 -1.02 -1.13 -1.26 -1.55 -1.36 guanine nucleotide binding protein (G
protein), beta polypeptide 2-like 1
Cell communication
NM 000183 HADHB -1.57 -1.61 hydroxyacyl-Coenzyme A
dehydrogenase/3-ketoacyl-Coenzyme
A thiolase/enoyl-Coenzyme A hy-
dratase (trifunctional protein), beta
subunit
Cellular lipid
metabolism
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Table 1 Continued
Accession No. Gene symbol 1# 2# 3# 4# 5# Gene description Biological process
NM 080820 HARS2 -2.56 -1.60 -1.31 histidyl-tRNA synthetase 2 Amino acid
metabolism
NM 178580 HM13 -1.49 -1.14 -1.82 -1.51 histocompatibility (minor) 13 Unknown
NM 001540 HSPA9B -2.03 -1.82 -1.12 -2.28 -1.57 heat shock 70 kDa protein 9B
(mortalin-2), nuclear gene encoding
mitochondrial protein
Cell cycle
NM 006764 IFRD2 -1.51 -1.42 -1.20 interferon-related developmental regu-
lator 2
Development
NM 000210 ITGA6 -1.82 -1.42 -1.10 -1.29 integrin, alpha 6 Cell adhesion
NM 002229 JUNB -1.19 -1.83 -1.79 -2.13 jun B proto-oncogene Transcrition
NM 015005 KIAA0284 -1.12 -1.26 -1.63 -1.29 KIAA0284 Unknown
NM 000421 KRT10 -1.24 -1.29 -1.05 -1.76 -1.50 keratin 10 (epidermolytic hyperkerato-
sis; keratosis palmaris et plantaris)
Development
NM 000422 KRT17 1.54 1.25 1.37 1.73 1.85 keratin 17 Development
NM 004138 KRTHA3A -1.47 -1.67 -1.30 -1.43 -1.02 keratin, hair, acidic, 3A Unknown
NM 005561 LAMP1 -1.94 -1.83 -1.23 -1.47 -1.41 lysosomal-associated membrane pro-
tein 1
Unknown
NM 018407 LAPTM4B -1.54 -1.42 -1.34 lysosomal-associated protein trans-
membrane 4 beta
Unknown
M 002300 LDHB -1.33 -1.49 1.08 -1.44 -1.62 lactate dehydrogenase BN Glucose metabolism
NM 031484 MARVELD1 -1.89 -2.13 -1.53 -1.49 MARVEL domain containing 1 Unknown
NM 014874 MFN2 -1.53 -1.48 -1.26 -1.22 mitofusin 2, nuclear gene encoding mi-
tochondrial protein
Cell cycle
NM 014046 MRPS18B -1.90 -1.74 mitochondrial ribosomal protein S18B,
nuclear gene encoding mitochondrial
protein
Protein metabolism
NM 002467 MYC -1.48 -2.64 -1.74 v-myc myelocytomatosis viral onco-
gene homolog (avian)
Cell cycle
NM 004559 NSEP1 -1.38 -1.45 1.24 -1.44 -1.55 nuclease sensitive element binding pro-
tein 1
Transcrition
NM 000918 P4HB -1.65 -1.63 -1.81 -1.27 procollagen-proline, 2-oxoglutarate 4-
dioxygenase, beta polypeptide (protein
disulfide isomerase-associated 1)
Protein metabolism
NM 005742 PDIA6 -2.35 -2.52 -1.65 -1.46 protein disulfide isomerase family A,
member 6
Unknown
NM 024895 PDZK7 -1.53 -1.47 -2.11 -1.53 1.02 PDZ domain containing 7 Unknown
NM 203473 PORCN -2.87 -2.43 -1.07 -1.49 -1.47 porcupine homolog (Drosophila)
(PORCN), transcript variant B
Unknown
NM 138689 PPP1R14B -1.35 -1.40 1.02 -1.49 -1.68 protein phosphatase 1, regulatory (in-
hibitor) subunit 14B
Unknown
NM 000310 PPT1 -1.97 -1.97 -1.53 -1.43 palmitoyl-protein thioesterase 1
(ceroid-lipofuscinosis, neuronal 1, in-
fantile)
Protein metabolism
NM 012094 PRDX5 -1.76 -1.58 -1.07 -1.07 peroxiredoxin 5, nuclear gene encoding
mitochondrial protein, transcript vari-
ant 1
Immune response
NM 212472 PRKAR1A -1.28 -1.34 -1.52 -1.66 protein kinase, cAMP-dependent, reg-
ulatory, type I, alpha (tissue specific
extinguisher 1)
Cell communication
NM 002862 PYGB -2.51 -1.55 -2.67 -1.75 phosphorylase, glycogen; brain Protein metabolism
NM 000967 RPL3 -1.56 -1.71 -1.02 -1.51 -1.33 ribosomal protein L3 Protein metabolism
NM 000968 RPL4 -1.45 -1.57 -1.32 -1.36 -1.16 ribosomal protein L4 Protein metabolism
NM 033251 RPL13 -1.25 -1.34 -1.30 -1.74 ribosomal protein L13 Protein metabolism
NM 002948 RPL15 -1.35 -1.57 1.19 -1.53 -1.52 ribosomal protein L15 Protein metabolism
NM 033251 RPL30 1.37 1.35 1.06 1.68 1.42 ribosomal protein L30 Protein metabolism
NM 033625 RPL34 1.47 1.32 -1.30 1.75 1.51 ribosomal protein L34 Protein metabolism
NM 053275 RPLP0 -1.29 -1.49 1.10 -1.17 -1.55 ribosomal protein, large, P0 Protein metabolism
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NM 002950 RPN1 -2.03 -1.65 -1.59 Homo sapiens ribophorin I Protein metabolism
NM 001005 RPS3 -1.57 -1.66 -1.34 -1.18 -1.02 ribosomal protein S3 Protein metabolism
NM 183352 SEC13L1 -1.51 -1.26 -1.02 -1.20 SEC13-like 1 (S. cerevisiae), transcript
variant 2
Development
NM 006640 SEPT9 -1.27 -1.78 -1.29 -1.53 septin 9 Unknown
NM 152264 SLC39A14 -1.62 -1.55 -1.29 -1.21 solute carrier family 39 (zinc trans-
porter), member 13
Unknown
NM 014426 SNX5 -1.16 -1.26 -1.53 -1.35 Sorting Nexin 5 Cell communication
NM 021102 SPINT2 -1.57 -1.67 1.07 -1.14 -1.23 serine protease inhibitor, Kunitz type,
2
Cell motility
NM 003145 SSR2 -1.22 -1.36 -1.14 -1.58 -1.38 signal sequence receptor, beta
(translocon-associated protein beta)
Cell organization
and biogenesis
NM 003146 SSRP1 -1.20 -1.69 -1.22 structure specific recognition protein 1 Transcrition
NM 152295 TARS -1.24 -1.57 -2.05 -1.19 threonyl-tRNA synthetase Protein metabolism
NM 012458 TIMM13 -1.63 -1.45 -1.02 -1.07 -1.35 translocase of inner mitochondrial
membrane 13 homolog (yeast), nuclear
gene encoding mitochondrial protein
Development
NM 003722 TP73L -1.51 -2.42 1.08 -1.82 -1.40 tumor protein p73-like Cell communication
NM 003329 TXN 1.69 2.06 2.21 1.98 thioredoxin Cell communication
NM 005080 XBP1 -1.61 -1.68 -1.64 -1.41 X-box binding protein 1 Transcrition
NM 003404 YWHAB -1.58 -1.46 1.49 -1.45 -1.61 tyrosine 3-monooxygenase/tryptophan
5-monooxygenase activation protein,
beta polypeptide, transcript variant 1
Unknown
CLUSTER III
NM 006317 BASP1 1.85 1.88 1.88 1.42 brain abundant, membrane attached
signal protein 1
Unknown
NM 000610 CD44 1.83 1.78 1.52 1.92 1.31 CD44 antigen Cell adhesion
NM 133467 CITED4 2.19 2.32 2.02 1.67 Cbp/p300-interacting transactivator,
with Glu/Asp-rich carboxy-terminal
domain, 4
Transcrition
NM 024045 DDX50 1.71 1.63 1.47 DEAD (Asp-Glu-Ala-Asp) box
polypeptide 50
Unknown
NM 001967 EIF4A2 2.28 1.98 1.41 1.63 eukaryotic translation initiation factor
4A, isoform 2
Protein metabolism
NM 004004 GJB2 2.49 1.95 1.47 2.21 gap junction protein, beta 2, 26 kDa
(connexin 26)
Cell communication
NM 004832 GSTO1 2.52 4.80 2.73 glutathione S-transferase omega 1 Unknown
NM 005345 HSPA1A 2.06 2.14 1.38 1.46 heat shock 70 kDa protein 1A Cell cycle
NM 006644 HSPH1 1.55 1.61 1.21 heat shock 105 kDa/110 kDa protein 1 Protein metabolism
NM 002658 PLAU 2.22 2.85 2.30 1.87 plasminogen activator, urokinase Cell communication
NM 002835 PTPN12 2.05 2.43 1.24 protein tyrosine phosphatase, non-
receptor type 12
Protein metabolism
NM 002872 RAC2 2.89 3.88 2.10 ras-related C3 botulinum toxin sub-
strate 2
Cell communication
NM 000539 RHO 1.74 1.69 rhodopsin (opsin 2, rod pigment) Cell communication
NM 020150 SARA1 1.75 1.84 2.04 SAR1a gene homolog 1 (S. cerevisiae) Cell communication
NM 021199 SQRDL 1.90 1.92 1.59 1.38 sulfide quinone reductase-like (yeast) Unknown
NM 020182 TMEPAI 1.73 2.34 1.59 2.48 1.80 transmembrane, prostate androgen in-
duced RNA, transcript variant 1
Cell communication
NM 005499 UBA2 1.67 1.48 1.10 1.21 SUMO-1 activating enzyme subunit 2 Protein metabolism
CLUSTER IV
NM 005946 MT1A 1.64 1.52 1.85 4.11 2.26 metallothionein 1A (functional) Unknown
NM 005947 MT1B 1.72 1.84 2.37 5.00 2.70 metallothionein 1B (functional) Unknown
NM 175617 MT1E 1.49 1.63 2.33 4.40 2.81 metallothionein 1E (functional) Unknown
NM 005950 MT1G 1.92 1.88 2.25 5.23 2.71 metallothionein 1G Unknown
NM 005951 MT1H 1.87 1.84 2.28 4.68 2.68 metallothionein 1H Unknown
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NM 005952 MT1X 1.88 1.76 2.28 4.54 2.48 metallothionein 1X Development
NM 005953 MT2A 2.21 2.09 2.57 6.38 2.86 metallothionein 2A Metal ion home-
ostasis
BC007034 ENST
00000245185
2.26 2.14 2.35 5.95 3.20 metallothionein 2A, mRNA (cDNA
clone MGC:12397 IMAGE:4051220)
Metal ion home-
ostasis
CLUSTER V
NM 001101 ACTB 1.19 1.14 1.21 1.51 1.29 actin, beta Cell cycle
NM 001102 ACTN1 2.08 2.23 actinin, alpha 1 Unknown
NM 004039 ANXA2 1.26 1.32 1.20 1.55 1.29 Annexin A2 Development
NM 006476 ATP5L 1.41 1.23 1.83 1.64 ATP synthase, H+ transporting, mito-
chondrial F0 complex, subunit g, nu-
clear gene encoding mitochondrial pro-
tein
Phophorylation
NM 178508 C6orf1 1.39 1.34 1.98 1.67 chromosome 6 open reading frame 1 Unknown
NM 016289 CAB39 2.01 1.77 calcium binding protein 39 Unknown
NM 006367 CAP1 1.47 1.44 1.84 1.30 adenylate cyclase-associated protein 1
(yeast)
Unknown
NM 152221 CSNK1E 1.60 1.22 1.16 1.60 1.33 casein kinase 1, epsilon, transcript
variant 1
Cell communication
AK074742 ENST
00000361624
-2.28 -1.38 -2.38 -1.49 -2.09 cDNA FLJ90261 fis, clone
NT2RM4000761
Unknown
NM 001997 FAU 1.15 1.10 1.03 1.53 1.60 Finkel-Biskis-Reilly murine sarcoma
virus (FBR-MuSV) ubiquitously ex-
pressed (fox derived); ribosomal pro-
tein S30 (FAU)
Protein metabolism
NM 001436 FBL -1.24 -1.57 -1.03 -1.14 fibrillarin RNA metabolism
M90686 HLA-G 2.95 3.24 lymphocyte antigen (HLA-G3) Immune response
NM 001540 HSBP1 1.86 1.87 1.92 heat shock 27 kDa protein 1 Transcrition
NM 000576 IL1B 1.25 1.41 2.26 1.39 interleukin 1, beta Immune response
NM 002192 INHBA 1.40 1.55 3.20 1.77 inhibin, beta A (activin A, activin AB
alpha polypeptide)
Cell cycle
NM 002305 LGALS1 1.55 1.18 1.22 2.25 1.36 lectin, galactoside-binding, soluble, 1
(galectin 1)
Cell communication
NM 004528 MGST3 2.23 1.59 microsomal glutathione S-transferase 3 Immune response
NM 079423 MYL6 1.49 1.40 -1.24 2.12 1.67 myosin, light polypeptide 6, alkali,
smooth muscle and non-muscle
Development
NM 004552 NDUFS5 1.19 1.25 -1.07 1.58 1.63 NADH dehydrogenase (ubiquinone)
Fe-S protein 5, 15 kDa (NADH-
coenzyme Q reductase) (NDUFS5)
Phophorylation
NM 002624 PFDN5 1.55 1.09 1.68 1.37 prefoldin 5, transcript variant 1 Protein metabolism
NM 007273 PHB2 -1.66 -1.50 1.11 -1.68 -1.76 prohibitin 2 Unknown
NM 021128 POLR2L 1.34 1.33 1.91 1.45 polymerase (RNA) II (DNA directed)
polypeptide L, 7.6 kDa
Transcrition
NM 002791 PSMA6 1.41 1.18 1.91 1.92 proteasome (prosome, macropain) sub-
unit, alpha type, 6
Protein metabolism
NM 006263 PSME1 1.04 1.29 2.09 1.85 proteasome (prosome, macropain) ac-
tivator subunit 1 (PA28 alpha)
Immune response
NM 006907 PYCR1 -2.57 -1.89 -1.00 -1.47 -1.36 pyrroline-5-carboxylate reductase 1,
transcript variant 1
Development
NM 175744 RHOC 1.30 1.28 1.57 1.28 ras homolog gene family, member C Unknown
NM 001026 RPS24 1.33 1.31 -1.19 1.71 1.68 ribosomal protein S24 Protein metabolism
NM 005979 S100A13 1.62 1.63 1.64 1.38 S100 calcium binding protein A13,
transcript variant 2
Development
NM 005978 S100A2 1.26 1.24 -1.27 2.29 1.59 S100 calcium binding protein A2 Development
NM 001018108 SERF2 1.27 1.49 1.09 1.71 1.78 small EDRK-rich factor 2 Unknown
NM 004607 TBCA 1.53 1.32 1.63 1.50 tubulin-specific chaperone a Protein metabolism
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NM 207013 TCEB2 1.22 1.26 1.85 1.89 transcription elongation factor B
(SIII), polypeptide 2 (18 kDa, elongin
B)
Protein metabolism
THC2276562 THC2276562 1.24 1.69 -1.31 1.96 2.56 limbic system-associated membrane
protein
Unknown
NM 021103 TMSB10 1.40 1.27 1.09 1.76 1.38 thymosin, beta 10 Cell organization
and biogenesis
NM 000365 TPT1 1.64 1.26 -1.34 1.73 1.43 triosephosphate isomerase 1 Cell cycle
NM 006086 TUBB3 1.66 1.56 1.71 1.52 tubulin, beta 3 Unknown
NM 006701 TXNL4A -1.21 -1.18 -1.59 -1.23 thioredoxin-like 4A Unknown
NM 024292 UBL5 1.46 1.57 2.21 1.87 ubiquitin-like 5 Protein metabolism
NM 003761 VAMP8 1.19 1.23 1.66 1.72 vesicle-associated membrane protein 8 Protein metabolism
NM 006373 VAT1 1.86 1.69 2.23 1.58 vesicle amine transport protein 1 ho-
molog (T californica)
Development
NM 006887 ZFP36L2 2.37 2.54 zinc finger protein 36, C3H type-like 2 Cell proliferation
*A total of 162 genes were identified from the five SMG experiments to be significantly (≥1.5-fold change, p ≤0.05)
differentially expressed. They were further categorized into 5 clusters and 18 functional groups. #1. Regulation value
of 3-day SMG. #2. Regulation value of 4-day SMG. #3. Regulation value of 4-day SMG plus 15-day recovery. #4.
Regulation value of 9-day SMG plus 50-day recovery. #5. Regulation value of 10-day SMG plus 60-day recovery.
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